25 XP   0   0   10

Alligator Bioscience AB
Buy, Hold or Sell?

Let's analyse Alligator Bioscience AB together

PenkeI guess you are interested in Alligator Bioscience AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Alligator Bioscience AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Alligator Bioscience AB

I send you an email if I find something interesting about Alligator Bioscience AB.

Quick analysis of Alligator Bioscience AB (30 sec.)










What can you expect buying and holding a share of Alligator Bioscience AB? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
5.9%

What is your share worth?

Current worth
kr0.02
Expected worth in 1 year
kr-0.10
How sure are you?
17.6%

+ What do you gain per year?

Total Gains per Share
kr-0.11
Return On Investment
-11.9%

For what price can you sell your share?

Current Price per Share
kr0.93
Expected price per share
kr0.8 - kr1.172
How sure are you?
50%

1. Valuation of Alligator Bioscience AB (5 min.)




Live pricePrice per Share (EOD)

kr0.93

Intrinsic Value Per Share

kr-3.50 - kr-4.11

Total Value Per Share

kr-3.48 - kr-4.09

2. Growth of Alligator Bioscience AB (5 min.)




Is Alligator Bioscience AB growing?

Current yearPrevious yearGrowGrow %
How rich?$1m$15.1m-$9.6m-173.9%

How much money is Alligator Bioscience AB making?

Current yearPrevious yearGrowGrow %
Making money-$5.6m-$4.4m-$1.2m-22.1%
Net Profit Margin-472.0%-740.0%--

How much money comes from the company's main activities?

3. Financial Health of Alligator Bioscience AB (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#838 / 1010

Most Revenue
#476 / 1010

Most Profit
#454 / 1010

Most Efficient
#727 / 1010

What can you expect buying and holding a share of Alligator Bioscience AB? (5 min.)

Welcome investor! Alligator Bioscience AB's management wants to use your money to grow the business. In return you get a share of Alligator Bioscience AB.

What can you expect buying and holding a share of Alligator Bioscience AB?

First you should know what it really means to hold a share of Alligator Bioscience AB. And how you can make/lose money.

Speculation

The Price per Share of Alligator Bioscience AB is kr0.925. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alligator Bioscience AB.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alligator Bioscience AB, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.02. Based on the TTM, the Book Value Change Per Share is kr-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alligator Bioscience AB.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.01-1.0%-0.01-0.9%-0.01-0.7%-0.01-0.7%0.00-0.4%
Usd Book Value Change Per Share-0.01-1.1%0.00-0.3%-0.01-0.7%0.00-0.3%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-1.1%0.00-0.3%-0.01-0.7%0.00-0.3%0.000.0%
Usd Price Per Share0.06-0.06-0.24-1.10-1.92-
Price to Earnings Ratio-1.62--1.81--9.25--46.18--85.28-
Price-to-Total Gains Ratio-6.47--5.75--36.95--160.04--327.33-
Price to Book Ratio38.24-18.41-11.89-39.21-38.84-
Price-to-Total Gains Ratio-6.47--5.75--36.95--160.04--327.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.084545
Number of shares11828
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (11828 shares)-29.67-37.09
Gains per Year (11828 shares)-118.69-148.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18-127-1292-150-158
216-254-2483-300-306
324-381-3675-450-454
433-507-4867-600-602
541-634-6058-750-750
649-761-72410-900-898
757-888-84311-1050-1046
865-1015-96213-1200-1194
973-1142-108115-1350-1342
1081-1268-120016-1500-1490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%3.031.00.08.8%3.031.06.07.5%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%3.017.00.015.0%6.025.03.017.6%8.026.06.020.0%
Dividend per Share2.00.02.050.0%2.00.010.016.7%2.00.018.010.0%2.00.032.05.9%2.00.038.05.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%3.017.00.015.0%6.025.03.017.6%8.026.06.020.0%

Fundamentals of Alligator Bioscience AB

About Alligator Bioscience AB

Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Sweden. The company's product portfolio includes Mitazalimab, a stimulatory antibody that targets CD40, which is in phase 2 clinical trial for the treatment of solid metastatic tumors, including pancreatic cancer; and ATOR-4066, tumor-directed bispecific antibody, developed using Neo-X-Prime technology platform for immunotherapy, which is in preclinical stage. It also offers ALG.APV-527, a bispecific antibody that targets the 4-1BB and 5T4 molecules, which is in phase 1 clinical trial for the treatment of solid metastatic tumors; and ATOR-1017, an immunostimulatory antibody, which is in phase 1 clinical trial for the treatment of metastatic cancer. In addition, the company develops products using its technology platforms, including ALLIGATOR-GOLD, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; ALLIGATOR-FAB, which is built on multiple scaffolds with optimal drug development properties to further increase the structural diversity of generated antibodies; FIND, a molecular evolution technology for optimization of antibodies and other proteins; and RUBY, a bispecific antibody format. Further, it has collaboration and out-licensing agreements with Aptevo Therapeutics, Inc.; Orion Corporation.; MacroGenics, Inc.; Biotheus Inc.; BioArctic AB; and Abclon Inc. The company was founded in 2000 and is headquartered in Lund, Sweden.

Fundamental data was last updated by Penke on 2024-04-19 08:28:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Alligator Bioscience AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Alligator Bioscience AB earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Alligator Bioscience AB to the Biotechnology industry mean.
  • A Net Profit Margin of -594.9% means that kr-5.95 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alligator Bioscience AB:

  • The MRQ is -594.9%. The company is making a huge loss. -2
  • The TTM is -472.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-594.9%TTM-472.0%-122.9%
TTM-472.0%YOY-740.0%+268.0%
TTM-472.0%5Y-14,517.7%+14,045.7%
5Y-14,517.7%10Y-9,984.4%-4,533.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-594.9%-207.2%-387.7%
TTM-472.0%-216.8%-255.2%
YOY-740.0%-282.3%-457.7%
5Y-14,517.7%-436.8%-14,080.9%
10Y-9,984.4%-597.3%-9,387.1%
1.1.2. Return on Assets

Shows how efficient Alligator Bioscience AB is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alligator Bioscience AB to the Biotechnology industry mean.
  • -59.0% Return on Assets means that Alligator Bioscience AB generated kr-0.59 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alligator Bioscience AB:

  • The MRQ is -59.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -41.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-59.0%TTM-41.9%-17.1%
TTM-41.9%YOY-22.4%-19.5%
TTM-41.9%5Y-23.2%-18.7%
5Y-23.2%10Y8.8%-32.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-59.0%-13.3%-45.7%
TTM-41.9%-12.8%-29.1%
YOY-22.4%-11.6%-10.8%
5Y-23.2%-13.8%-9.4%
10Y8.8%-15.6%+24.4%
1.1.3. Return on Equity

Shows how efficient Alligator Bioscience AB is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alligator Bioscience AB to the Biotechnology industry mean.
  • -589.0% Return on Equity means Alligator Bioscience AB generated kr-5.89 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alligator Bioscience AB:

  • The MRQ is -589.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -235.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-589.0%TTM-235.6%-353.4%
TTM-235.6%YOY-34.6%-201.0%
TTM-235.6%5Y-67.1%-168.6%
5Y-67.1%10Y-12.4%-54.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-589.0%-16.9%-572.1%
TTM-235.6%-16.1%-219.5%
YOY-34.6%-14.9%-19.7%
5Y-67.1%-19.3%-47.8%
10Y-12.4%-20.1%+7.7%

1.2. Operating Efficiency of Alligator Bioscience AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Alligator Bioscience AB is operating .

  • Measures how much profit Alligator Bioscience AB makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alligator Bioscience AB to the Biotechnology industry mean.
  • An Operating Margin of -609.6% means the company generated kr-6.10  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alligator Bioscience AB:

  • The MRQ is -609.6%. The company is operating very inefficient. -2
  • The TTM is -473.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-609.6%TTM-473.6%-136.0%
TTM-473.6%YOY-739.7%+266.2%
TTM-473.6%5Y-14,483.4%+14,009.9%
5Y-14,483.4%10Y-9,918.5%-4,564.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-609.6%-298.0%-311.6%
TTM-473.6%-238.5%-235.1%
YOY-739.7%-288.4%-451.3%
5Y-14,483.4%-486.2%-13,997.2%
10Y-9,918.5%-628.4%-9,290.1%
1.2.2. Operating Ratio

Measures how efficient Alligator Bioscience AB is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 6.87 means that the operating costs are kr6.87 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Alligator Bioscience AB:

  • The MRQ is 6.868. The company is inefficient in keeping operating costs low. -1
  • The TTM is 9.074. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.868TTM9.074-2.206
TTM9.074YOY8.400+0.674
TTM9.0745Y237.059-227.985
5Y237.05910Y163.952+73.107
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.8683.235+3.633
TTM9.0743.310+5.764
YOY8.4003.838+4.562
5Y237.0595.679+231.380
10Y163.9527.823+156.129

1.3. Liquidity of Alligator Bioscience AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Alligator Bioscience AB is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.79 means the company has kr0.79 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Alligator Bioscience AB:

  • The MRQ is 0.789. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.304. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.789TTM1.304-0.515
TTM1.304YOY3.964-2.659
TTM1.3045Y4.598-3.293
5Y4.59810Y10.223-5.625
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7893.863-3.074
TTM1.3044.169-2.865
YOY3.9645.337-1.373
5Y4.5986.122-1.524
10Y10.2236.434+3.789
1.3.2. Quick Ratio

Measures if Alligator Bioscience AB is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alligator Bioscience AB to the Biotechnology industry mean.
  • A Quick Ratio of 0.75 means the company can pay off kr0.75 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alligator Bioscience AB:

  • The MRQ is 0.751. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.404. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ0.751TTM1.404-0.653
TTM1.404YOY3.823-2.419
TTM1.4045Y4.587-3.183
5Y4.58710Y10.194-5.607
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7513.504-2.753
TTM1.4043.991-2.587
YOY3.8235.371-1.548
5Y4.5876.088-1.501
10Y10.1946.395+3.799

1.4. Solvency of Alligator Bioscience AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Alligator Bioscience AB assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alligator Bioscience AB to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.90 means that Alligator Bioscience AB assets are financed with 90.0% credit (debt) and the remaining percentage (100% - 90.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alligator Bioscience AB:

  • The MRQ is 0.900. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.673. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.900TTM0.673+0.226
TTM0.673YOY0.301+0.372
TTM0.6735Y0.306+0.368
5Y0.30610Y0.201+0.105
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9000.339+0.561
TTM0.6730.337+0.336
YOY0.3010.271+0.030
5Y0.3060.368-0.062
10Y0.2010.388-0.187
1.4.2. Debt to Equity Ratio

Measures if Alligator Bioscience AB is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alligator Bioscience AB to the Biotechnology industry mean.
  • A Debt to Equity ratio of 899.2% means that company has kr8.99 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alligator Bioscience AB:

  • The MRQ is 8.992. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.670. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ8.992TTM3.670+5.322
TTM3.670YOY0.471+3.199
TTM3.6705Y0.969+2.700
5Y0.96910Y0.593+0.376
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9920.392+8.600
TTM3.6700.403+3.267
YOY0.4710.335+0.136
5Y0.9690.427+0.542
10Y0.5930.461+0.132

2. Market Valuation of Alligator Bioscience AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Alligator Bioscience AB generates.

  • Above 15 is considered overpriced but always compare Alligator Bioscience AB to the Biotechnology industry mean.
  • A PE ratio of -1.62 means the investor is paying kr-1.62 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alligator Bioscience AB:

  • The EOD is -2.179. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.623. Based on the earnings, the company is expensive. -2
  • The TTM is -1.813. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.179MRQ-1.623-0.556
MRQ-1.623TTM-1.813+0.190
TTM-1.813YOY-9.250+7.437
TTM-1.8135Y-46.180+44.367
5Y-46.18010Y-85.277+39.097
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.179-2.300+0.121
MRQ-1.623-2.656+1.033
TTM-1.813-2.718+0.905
YOY-9.250-4.145-5.105
5Y-46.180-6.258-39.922
10Y-85.277-6.315-78.962
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alligator Bioscience AB:

  • The EOD is -2.792. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.079. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.340. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.792MRQ-2.079-0.712
MRQ-2.079TTM-2.340+0.261
TTM-2.340YOY-9.991+7.650
TTM-2.3405Y-52.851+50.511
5Y-52.85110Y177.503-230.354
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.792-2.974+0.182
MRQ-2.079-3.306+1.227
TTM-2.340-3.508+1.168
YOY-9.991-5.613-4.378
5Y-52.851-8.378-44.473
10Y177.503-8.873+186.376
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Alligator Bioscience AB is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 38.24 means the investor is paying kr38.24 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Alligator Bioscience AB:

  • The EOD is 51.338. Based on the equity, the company is expensive. -2
  • The MRQ is 38.240. Based on the equity, the company is expensive. -2
  • The TTM is 18.409. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD51.338MRQ38.240+13.098
MRQ38.240TTM18.409+19.831
TTM18.409YOY11.890+6.519
TTM18.4095Y39.209-20.800
5Y39.20910Y38.836+0.373
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD51.3381.914+49.424
MRQ38.2402.116+36.124
TTM18.4092.097+16.312
YOY11.8902.881+9.009
5Y39.2093.550+35.659
10Y38.8363.936+34.900
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Alligator Bioscience AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.106-0.029-72%-0.073-31%-0.035-67%-0.001-99%
Book Value Per Share--0.0180.092-80%0.252-93%0.273-93%0.467-96%
Current Ratio--0.7891.304-40%3.964-80%4.598-83%10.223-92%
Debt To Asset Ratio--0.9000.673+34%0.301+199%0.306+194%0.201+348%
Debt To Equity Ratio--8.9923.670+145%0.471+1809%0.969+828%0.593+1416%
Dividend Per Share---0.002-100%-0%0.000-100%0.000-100%
Eps---0.106-0.094-11%-0.073-31%-0.071-33%-0.043-60%
Free Cash Flow Per Share---0.083-0.073-12%-0.067-19%-0.062-25%-0.038-55%
Free Cash Flow To Equity Per Share---0.011-0.011+7%-0.069+541%-0.028+163%0.007-261%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---4.108--------
Intrinsic Value_10Y_min---3.501--------
Intrinsic Value_1Y_max---0.274--------
Intrinsic Value_1Y_min---0.269--------
Intrinsic Value_3Y_max---0.929--------
Intrinsic Value_3Y_min---0.885--------
Intrinsic Value_5Y_max---1.710--------
Intrinsic Value_5Y_min---1.578--------
Market Cap608607435.200+26%453330505.810454070545.9170%1762510683.490-74%7896507124.456-94%13833279328.130-97%
Net Profit Margin---5.949-4.720-21%-7.400+24%-145.177+2340%-99.844+1578%
Operating Margin---6.096-4.736-22%-7.397+21%-144.834+2276%-99.185+1527%
Operating Ratio--6.8689.074-24%8.400-18%237.059-97%163.952-96%
Pb Ratio51.338+26%38.24018.409+108%11.890+222%39.209-2%38.836-2%
Pe Ratio-2.179-34%-1.623-1.813+12%-9.250+470%-46.180+2745%-85.277+5154%
Price Per Share0.925+26%0.6890.6900%2.679-74%12.002-94%21.025-97%
Price To Free Cash Flow Ratio-2.792-34%-2.079-2.340+13%-9.991+380%-52.851+2442%177.503-101%
Price To Total Gains Ratio-8.689-34%-6.472-5.746-11%-36.953+471%-160.039+2373%-327.334+4957%
Quick Ratio--0.7511.404-47%3.823-80%4.587-84%10.194-93%
Return On Assets---0.590-0.419-29%-0.224-62%-0.232-61%0.088-770%
Return On Equity---5.890-2.356-60%-0.346-94%-0.671-89%-0.124-98%
Total Gains Per Share---0.106-0.027-74%-0.073-31%-0.034-68%-0.001-100%
Usd Book Value--1083547.0005532282.050-80%15150441.150-93%16400720.030-93%28100205.252-96%
Usd Book Value Change Per Share---0.010-0.003-72%-0.007-31%-0.003-67%0.000-99%
Usd Book Value Per Share--0.0020.008-80%0.023-93%0.025-93%0.043-96%
Usd Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Usd Eps---0.010-0.009-11%-0.007-31%-0.007-33%-0.004-60%
Usd Free Cash Flow---4981391.400-4381396.100-12%-4032613.700-19%-3734019.040-25%-2257077.300-55%
Usd Free Cash Flow Per Share---0.008-0.007-12%-0.006-19%-0.006-25%-0.003-55%
Usd Free Cash Flow To Equity Per Share---0.001-0.001+7%-0.006+541%-0.003+163%0.001-261%
Usd Market Cap55626719.577+26%41434408.23141502047.8970%161093476.471-74%721740751.175-94%1264361730.591-97%
Usd Price Per Share0.085+26%0.0630.0630%0.245-74%1.097-94%1.922-97%
Usd Profit---6382462.000-5688827.400-11%-4433996.800-31%-4287263.240-33%-2583851.118-60%
Usd Revenue--1072853.2001327744.950-19%815630.750+32%527629.350+103%1471429.782-27%
Usd Total Gains Per Share---0.010-0.003-74%-0.007-31%-0.003-68%0.000-100%
 EOD+5 -3MRQTTM+4 -31YOY+8 -255Y+9 -2610Y+7 -28

3.2. Fundamental Score

Let's check the fundamental score of Alligator Bioscience AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.179
Price to Book Ratio (EOD)Between0-151.338
Net Profit Margin (MRQ)Greater than0-5.949
Operating Margin (MRQ)Greater than0-6.096
Quick Ratio (MRQ)Greater than10.751
Current Ratio (MRQ)Greater than10.789
Debt to Asset Ratio (MRQ)Less than10.900
Debt to Equity Ratio (MRQ)Less than18.992
Return on Equity (MRQ)Greater than0.15-5.890
Return on Assets (MRQ)Greater than0.05-0.590
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Alligator Bioscience AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.522
Ma 20Greater thanMa 501.003
Ma 50Greater thanMa 1001.040
Ma 100Greater thanMa 2000.984
OpenGreater thanClose0.917
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Interest Expense  792-439353-165188-37151-275-124



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets118,450
Total Liabilities106,595
Total Stockholder Equity11,855
 As reported
Total Liabilities 106,595
Total Stockholder Equity+ 11,855
Total Assets = 118,450

Assets

Total Assets118,450
Total Current Assets78,188
Long-term Assets40,262
Total Current Assets
Cash And Cash Equivalents 66,118
Net Receivables 8,322
Inventory 0
Other Current Assets 3,748
Total Current Assets  (as reported)78,188
Total Current Assets  (calculated)78,188
+/-0
Long-term Assets
Property Plant Equipment 20,312
Intangible Assets 17,964
Long-term Assets  (as reported)40,262
Long-term Assets  (calculated)38,276
+/- 1,986

Liabilities & Shareholders' Equity

Total Current Liabilities99,079
Long-term Liabilities7,516
Total Stockholder Equity11,855
Total Current Liabilities
Short-term Debt 8,581
Accounts payable 21,273
Other Current Liabilities 68,670
Total Current Liabilities  (as reported)99,079
Total Current Liabilities  (calculated)98,524
+/- 555
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt7,516
Long-term Liabilities  (as reported)7,516
Long-term Liabilities  (calculated)7,516
+/-0
Total Stockholder Equity
Common Stock42,170
Retained Earnings -1,085,539
Other Stockholders Equity 1,055,224
Total Stockholder Equity (as reported)11,855
Total Stockholder Equity (calculated)11,855
+/-0
Other
Capital Stock42,170
Cash and Short Term Investments 66,118
Common Stock Shares Outstanding 657,954
Current Deferred Revenue555
Liabilities and Stockholders Equity 118,450
Net Debt -50,021
Net Invested Capital 11,855
Net Working Capital -20,891
Property Plant and Equipment Gross 88,504
Short Long Term Debt Total 16,097



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-312011-12-312011-03-312010-12-312009-06-302009-03-312008-12-312008-09-302008-03-312007-12-312006-12-312005-12-31
> Total Assets 
16,678
17,290
47,849
0
19,539
19,539
17,227
17,227
9,581
34,020
30,619
97,794
0
416,256
0
0
383,301
700,780
676,610
652,832
626,917
643,033
598,816
565,151
525,463
508,156
468,126
420,849
371,743
311,128
259,620
222,113
187,590
151,938
191,703
155,459
131,822
333,200
295,020
251,451
205,054
169,584
122,061
223,950
184,100
118,450
118,450184,100223,950122,061169,584205,054251,451295,020333,200131,822155,459191,703151,938187,590222,113259,620311,128371,743420,849468,126508,156525,463565,151598,816643,033626,917652,832676,610700,780383,30100416,256097,79430,61934,0209,58117,22717,22719,53919,539047,84917,29016,678
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
370,417
0
0
358,401
676,178
651,045
551,590
523,592
533,311
485,262
452,143
423,740
417,545
356,313
311,787
265,217
205,992
210,365
175,759
144,022
110,345
153,057
121,782
94,377
299,613
249,832
208,859
165,219
122,814
75,938
178,247
141,095
78,188
78,188141,095178,24775,938122,814165,219208,859249,832299,61394,377121,782153,057110,345144,022175,759210,365205,992265,217311,787356,313417,545423,740452,143485,262533,311523,592551,590651,045676,178358,40100370,4170000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
365,605
0
0
346,457
659,136
639,739
540,515
513,220
472,919
474,684
444,575
404,688
362,878
329,533
284,950
239,281
196,870
203,218
169,757
136,964
103,342
143,660
109,705
79,314
278,148
234,448
192,913
147,411
97,305
44,837
160,552
73,919
66,118
66,11873,919160,55244,83797,305147,411192,913234,448278,14879,314109,705143,660103,342136,964169,757203,218196,870239,281284,950329,533362,878404,688444,575474,684472,919513,220540,515639,739659,136346,45700365,6050000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,189
20,254
20,161
20,068
10,012
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
0
050,00000000000000000010,01220,06820,16120,25410,189000000000000000000000000
       Net Receivables 
4,086
813
959
0
1,379
1,379
1,195
1,195
1,088
1,158
2,294
2,740
0
3,810
0
0
7,743
15,735
6,528
6,535
7,999
58,797
7,034
3,546
4,280
32,772
40
30
4,934
7,553
4,062
4,215
4,980
6,089
4,241
5,867
8,991
16,310
10,027
10,340
11,317
13,930
31,100
14,630
10,843
8,322
8,32210,84314,63031,10013,93011,31710,34010,02716,3108,9915,8674,2416,0894,9804,2154,0627,5534,934304032,7724,2803,5467,03458,7977,9996,5356,52815,7357,743003,81002,7402,2941,1581,0881,1951,1951,3791,37909598134,086
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
45,840
0
0
24,900
24,603
25,564
101,242
103,325
109,722
113,554
113,008
101,723
90,612
111,813
109,062
106,527
105,136
49,255
46,355
43,568
41,593
38,646
33,677
37,445
33,587
45,188
42,593
39,835
46,770
46,123
45,704
43,005
40,262
40,26243,00545,70446,12346,77039,83542,59345,18833,58737,44533,67738,64641,59343,56846,35549,255105,136106,527109,062111,81390,612101,723113,008113,554109,722103,325101,24225,56424,60324,9000045,8400000000000000
       Property Plant Equipment 
2,540
1,708
1,926
0
2,821
2,821
2,341
2,341
1,460
1,302
1,153
2,305
0
2,323
0
0
4,322
4,349
5,553
6,970
9,335
16,198
20,391
20,191
18,937
18,237
39,660
37,114
34,686
33,475
30,701
27,881
25,160
23,238
20,344
15,433
19,235
15,418
27,060
24,505
21,784
26,935
26,317
25,618
22,978
20,312
20,31222,97825,61826,31726,93521,78424,50527,06015,41819,23515,43320,34423,23825,16027,88130,70133,47534,68637,11439,66018,23718,93720,19120,39116,1989,3356,9705,5534,3494,322002,32302,3051,1531,3021,4602,3412,3412,8212,82101,9261,7082,540
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
74,508
74,358
74,122
73,968
73,819
63,477
53,259
53,211
53,161
53,077
53,016
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000053,01653,07753,16153,21153,25963,47773,81973,96874,12274,35874,5080000000000000000000
       Intangible Assets 
145
52
0
0
2,997
2,997
3,469
3,469
3,429
3,499
5,777
54,083
0
43,423
0
0
20,484
20,255
20,012
19,764
19,633
19,403
19,195
18,999
19,310
19,115
18,943
18,788
18,763
18,645
18,553
18,474
18,408
18,353
18,303
18,245
18,210
18,167
18,127
18,089
18,052
18,019
17,991
17,976
17,970
17,964
17,96417,97017,97617,99118,01918,05218,08918,12718,16718,21018,24518,30318,35318,40818,47418,55318,64518,76318,78818,94319,11519,31018,99919,19519,40319,63319,76420,01220,25520,4840043,423054,0835,7773,4993,4293,4693,4692,9972,9970052145
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
94
0
0
94
-1
-1
74,508
74,357
74,121
73,968
73,818
10,188
20,255
20,160
20,067
10,013
53,016
1
0
0
2
-1
-1
0
2
1
-1
-1
1,816
1,815
2,110
50,000
0
050,0002,1101,8151,816-1-1120-1-1200153,01610,01320,06720,16020,25510,18873,81873,96874,12174,35774,508-1-19400940000000000000
> Total Liabilities 
13,446
6,384
6,409
0
6,968
6,968
7,891
7,891
8,448
5,551
9,111
29,275
0
19,287
0
0
12,447
24,595
14,552
21,708
21,519
25,077
22,900
26,856
26,684
39,846
44,083
46,037
53,533
52,630
43,949
41,532
37,845
36,694
34,457
33,184
46,793
50,927
56,512
58,227
62,798
80,533
95,535
102,115
102,203
106,595
106,595102,203102,11595,53580,53362,79858,22756,51250,92746,79333,18434,45736,69437,84541,53243,94952,63053,53346,03744,08339,84626,68426,85622,90025,07721,51921,70814,55224,59512,4470019,287029,2759,1115,5518,4487,8917,8916,9686,96806,4096,38413,446
   > Total Current Liabilities 
6,039
6,384
6,409
0
6,968
6,968
7,891
7,891
8,448
5,551
9,111
29,275
0
19,287
0
0
12,447
24,595
14,552
21,708
21,519
25,078
22,901
26,856
26,684
39,847
28,954
32,311
41,009
40,944
33,806
32,935
30,828
30,719
30,200
30,466
42,571
47,416
41,331
44,800
50,920
64,529
81,593
90,322
92,563
99,079
99,07992,56390,32281,59364,52950,92044,80041,33147,41642,57130,46630,20030,71930,82832,93533,80640,94441,00932,31128,95439,84726,68426,85622,90125,07821,51921,70814,55224,59512,4470019,287029,2759,1115,5518,4487,8917,8916,9686,96806,4096,3846,039
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,545
5,573
5,675
5,794
5,823
5,853
5,907
6,232
7,712
5,853
7,295
6,225
7,225
7,261
7,068
8,499
9,380
9,100
8,810
8,581
8,5818,8109,1009,3808,4997,0687,2617,2256,2257,2955,8537,7126,2325,9075,8535,8235,7945,6755,5735,54500000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,545
5,573
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000005,5735,54500000000000000000000000000
       Accounts payable 
1,520
2,425
1,490
0
2,500
2,500
2,045
2,045
2,108
1,263
3,490
4,195
0
4,890
0
0
3,064
13,340
6,657
12,064
10,388
13,569
11,309
10,462
13,276
17,702
7,270
7,167
5,787
15,674
8,818
4,336
4,639
6,538
7,014
3,263
7,078
9,367
3,134
4,866
4,362
13,343
10,266
11,455
11,966
21,273
21,27311,96611,45510,26613,3434,3624,8663,1349,3677,0783,2637,0146,5384,6394,3368,81815,6745,7877,1677,27017,70213,27610,46211,30913,56910,38812,0646,65713,3403,064004,89004,1953,4901,2632,1082,0452,0452,5002,50001,4902,4251,520
       Other Current Liabilities 
4,519
3,959
4,919
0
4,468
4,468
4,847
4,847
6,339
4,288
5,621
25,080
0
14,397
0
0
9,383
11,255
7,895
9,644
11,131
11,509
11,592
16,394
13,408
22,145
16,139
19,571
29,547
19,476
19,165
22,746
20,282
17,949
15,474
21,350
28,198
31,824
30,972
32,673
39,490
42,687
61,947
4,028
1,808
68,670
68,6701,8084,02861,94742,68739,49032,67330,97231,82428,19821,35015,47417,94920,28222,74619,16519,47629,54719,57116,13922,14513,40816,39411,59211,50911,1319,6447,89511,2559,3830014,397025,0805,6214,2886,3394,8474,8474,4684,46804,9193,9594,519
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
-1
0
0
-1
15,129
13,726
12,524
11,686
10,143
8,597
7,017
5,975
4,257
2,718
4,222
3,511
15,181
13,427
11,878
16,004
13,942
11,793
9,640
7,516
7,5169,64011,79313,94216,00411,87813,42715,1813,5114,2222,7184,2575,9757,0178,59710,14311,68612,52413,72615,129-100-1-1000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,841
4,033
2,573
4,222
3,511
15,181
13,427
11,877
16,003
13,942
11,794
0
0
0011,79413,94216,00311,87713,42715,1813,5114,2222,5734,0335,841000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
-1
0
0
-1
0
0
-1
426
350
279
205
134
224
145
1
0
0
0
1
1
0
-1
0
0
00-10110001145224134205279350426-100-100-1-1000000000000000000000
> Total Stockholder Equity
3,232
10,907
41,440
41,440
12,570
12,570
9,336
9,336
1,134
28,470
21,508
68,519
0
396,969
396,969
0
370,854
676,185
662,058
631,124
605,398
617,956
575,916
538,295
498,779
468,310
424,043
374,812
318,210
258,498
215,671
180,581
149,745
115,244
157,246
122,275
85,029
282,273
238,508
193,224
142,256
89,051
26,526
121,835
81,897
11,855
11,85581,897121,83526,52689,051142,256193,224238,508282,27385,029122,275157,246115,244149,745180,581215,671258,498318,210374,812424,043468,310498,779538,295575,916617,956605,398631,124662,058676,185370,8540396,969396,969068,51921,50828,4701,1349,3369,33612,57012,57041,44041,44010,9073,232
   Common Stock
2,913
3,887
4,875
0
4,875
4,875
4,875
4,875
6,114
7,550
21,508
19,445
0
23,606
0
0
23,698
28,045
28,555
28,555
28,555
28,555
28,555
28,555
28,555
28,555
28,555
28,555
28,555
28,555
28,555
28,555
28,555
28,555
34,267
34,267
34,267
88,234
88,614
88,614
88,614
88,614
88,614
39,970
42,170
42,170
42,17042,17039,97088,61488,61488,61488,61488,61488,23434,26734,26734,26728,55528,55528,55528,55528,55528,55528,55528,55528,55528,55528,55528,55528,55528,55528,55528,55528,04523,6980023,606019,44521,5087,5506,1144,8754,8754,8754,87504,8753,8872,913
   Retained Earnings 
318
0
0
0
0
0
0
0
0
0
0
0
0
38,312
0
0
9,390
-9,809
-29,112
-60,045
-85,771
-73,214
-115,254
-152,875
-192,390
-222,860
-267,127
-316,357
-372,960
-432,671
-475,498
-510,589
-541,424
-575,926
-608,787
-643,757
-681,003
-717,792
-761,223
-806,933
-858,271
-911,463
-973,982
-963,239
-1,015,731
-1,085,539
-1,085,539-1,015,731-963,239-973,982-911,463-858,271-806,933-761,223-717,792-681,003-643,757-608,787-575,926-541,424-510,589-475,498-432,671-372,960-316,357-267,127-222,860-192,390-152,875-115,254-73,214-85,771-60,045-29,112-9,8099,3900038,312000000000000318
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
662,614
662,614
662,614
662,614
662,614
731,767
731,765
731,765
911,831
911,118
911,544
911,914
911,901
911,894
1,045,104
0
0
001,045,104911,894911,901911,914911,544911,118911,831731,765731,765731,767662,614662,614662,614662,614662,61400000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
335,051
0
0
337,766
657,949
662,615
662,614
662,614
662,615
662,615
662,615
662,614
662,615
662,615
662,614
662,615
662,614
662,614
662,615
662,614
662,615
731,766
731,765
731,765
911,831
911,117
911,543
911,913
911,900
911,894
1,045,104
1,055,458
1,055,224
1,055,2241,055,4581,045,104911,894911,900911,913911,543911,117911,831731,765731,765731,766662,615662,614662,615662,614662,614662,615662,614662,615662,615662,614662,615662,615662,615662,614662,614662,615657,949337,76600335,0510000000000000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue58,107
Cost of Revenue-0
Gross Profit58,10758,107
 
Operating Income (+$)
Gross Profit58,107
Operating Expense-300,395
Operating Income-252,777-242,288
 
Operating Expense (+$)
Research Development264,585
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense300,395264,585
 
Net Interest Income (+$)
Interest Income299
Interest Expense-483
Other Finance Cost-611
Net Interest Income-795
 
Pretax Income (+$)
Operating Income-252,777
Net Interest Income-795
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-248,586-256,968
EBIT - interestExpense = -253,260
-248,586
-248,103
Interest Expense483
Earnings Before Interest and Taxes (EBIT)-252,777-248,103
Earnings Before Interest and Taxes (EBITDA)-242,288
 
After tax Income (+$)
Income Before Tax-248,586
Tax Provision-0
Net Income From Continuing Ops-232,007-248,586
Net Income-248,586
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses310,884
Total Other Income/Expenses Net4,191795
 

Technical Analysis of Alligator Bioscience AB
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alligator Bioscience AB. The general trend of Alligator Bioscience AB is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alligator Bioscience AB's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alligator Bioscience AB.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.921 < 0.935 < 1.172.

The bearish price targets are: 0.912 > 0.827 > 0.8.

Tweet this
Alligator Bioscience AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alligator Bioscience AB. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alligator Bioscience AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alligator Bioscience AB. The current macd is -0.02302617.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alligator Bioscience AB price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Alligator Bioscience AB. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Alligator Bioscience AB price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Alligator Bioscience AB Daily Moving Average Convergence/Divergence (MACD) ChartAlligator Bioscience AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alligator Bioscience AB. The current adx is 24.05.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Alligator Bioscience AB shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Alligator Bioscience AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alligator Bioscience AB. The current sar is 1.11646135.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Alligator Bioscience AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alligator Bioscience AB. The current rsi is 37.52. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Alligator Bioscience AB Daily Relative Strength Index (RSI) ChartAlligator Bioscience AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alligator Bioscience AB. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Alligator Bioscience AB price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Alligator Bioscience AB Daily Stochastic Oscillator ChartAlligator Bioscience AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alligator Bioscience AB. The current cci is -157.16898832.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Alligator Bioscience AB Daily Commodity Channel Index (CCI) ChartAlligator Bioscience AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alligator Bioscience AB. The current cmo is -37.1110849.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Alligator Bioscience AB Daily Chande Momentum Oscillator (CMO) ChartAlligator Bioscience AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alligator Bioscience AB. The current willr is -85.66775244.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Alligator Bioscience AB Daily Williams %R ChartAlligator Bioscience AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Alligator Bioscience AB.

Alligator Bioscience AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alligator Bioscience AB. The current atr is 0.06443461.

Alligator Bioscience AB Daily Average True Range (ATR) ChartAlligator Bioscience AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alligator Bioscience AB. The current obv is 9,986,110.

Alligator Bioscience AB Daily On-Balance Volume (OBV) ChartAlligator Bioscience AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alligator Bioscience AB. The current mfi is 16.26.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Alligator Bioscience AB Daily Money Flow Index (MFI) ChartAlligator Bioscience AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alligator Bioscience AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Alligator Bioscience AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alligator Bioscience AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.522
Ma 20Greater thanMa 501.003
Ma 50Greater thanMa 1001.040
Ma 100Greater thanMa 2000.984
OpenGreater thanClose0.917
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Alligator Bioscience AB with someone you think should read this too:
  • Are you bullish or bearish on Alligator Bioscience AB? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alligator Bioscience AB? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alligator Bioscience AB

I send you an email if I find something interesting about Alligator Bioscience AB.


Comments

How you think about this?

Leave a comment

Stay informed about Alligator Bioscience AB.

Receive notifications about Alligator Bioscience AB in your mailbox!